P3 HEALTH PARTNERS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5056 USD | +0.92% |
|
-13.53% | -64.14% |
| Apr. 01 | BTIG Research Downgrades P3 Health Partners to Neutral From Buy | MT |
| Mar. 28 | Transcript : P3 Health Partners Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Chart calendar P3 Health Partners Inc.
b513719f12c91f2.LilMKrO9IUNyk9bUH3UXSu91GPkMbBb82q7QiraHzOE.G20tff_HVAxD_rmAeBpFP5csQINqDlrMk9ak8oH-orNLaBhbwtNFcx2lkw~b7382cbcffd9bc2c5627ddd1207132b2
Upcoming events on P3 Health Partners Inc.
Past events on P3 Health Partners Inc.
| 2024-04-11 01:30 pm | Needham Healthcare Conference |
| 2024-03-28 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-28 04:05 pm | Q4 2023 Earnings Release |
| 2024-03-19 03:45 pm | KeyBanc Life Sciences & MedTech Forum |
| 2024-03-10 | Jefferies Value-Based Healthcare Summit |
| 2024-03-04 10:30 am | TD Cowen Health Care Conference |
| 2024-02-12 | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
| 2024-01-10 04:30 pm | JPMorgan Healthcare Conference |
| 2023-11-20 03:00 pm | BTIG Digital Health Forum |
| 2023-11-08 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-08 04:02 pm | Q3 2023 Earnings Release |
| 2023-09-13 | Lake Street Capital Markets Big7 Conference |
| 2023-09-07 04:30 pm | Wells Fargo Healthcare Conference |
| 2023-08-07 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-07 04:05 pm | Q2 2023 Earnings Release |
| 2023-07-24 12:00 pm | Annual General Meeting |
| 2023-05-10 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-10 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-31 08:30 am | Q4 2022 Earnings Call |
| 2023-03-31 07:11 am | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 637 643 -0.81% | 1 050 1 046 0.31% | 1 266 1 222 3.6% | 1 494 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -95,5 -83,6 -14.22% | -128 -125 -1.99% | -85,5 -46,8 -82.68% | 1,20 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -188 -115 -63.86% | -1 561 -1 087 -43.64% | -168 -130 -28.98% | -92,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -1 560 -1 094 -42.53% | -184 -144 -28% | -111 |
|
Net income Million USD | Released Forecast Spread | -41,1 | 0,00 0,00 - | -270 -241 -11.98% | -57,8 -42,5 -35.92% | -60,0 |
|
EPS USD | Released Forecast Spread | -0,62 | 0,00 0,00 - | -6,50 -5,80 -12.07% | -0,63 -0,74 14.86% | -0,35 |
| Announcement Date | 12/08/21 | 21/10/22 | 31/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 178 183 -2.86% | 274 225 21.79% | 269 228 18.44% | 248 257 -3.23% | 258 255 1.25% | 302 281 7.67% | 329 303 8.51% | 288 293 -1.67% | 347 303 14.58% | 357 | 369 | 368 | 400 | 426 |
|
EBITDA Million USD | Released Forecast Spread | -43,1 -31,2 -37.99% | -18,9 -24,4 22.43% | -28,6 -6,90 -314.49% | -40,3 -14,3 -181.87% | -40,1 -37,5 -6.93% | -19,1 -19,1 -0.17% | 0,22 -12,6 101.72% | -22,3 -12,5 -78.04% | -44,3 -5,29 -736.16% | -14,4 | -7,46 | 8,83 | 14,2 | 6,10 |
|
EBIT Million USD | Released Forecast Spread | -127 -54,2 -135.05% | -52,2 -40,9 -27.55% | -912 -23,6 -3765.2% | -60,0 -48,5 -23.86% | -537 -62,4 -759.78% | -48,8 -49,3 0.88% | -21,0 -40,5 48.07% | -33,8 -34,6 2.29% | -64,3 -26,5 -142.43% | -37,5 | -31,5 | -14,9 | -8,24 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -65,3 -49,5 -31.98% | -531 -65,1 -714.9% | -52,2 -50,9 -2.57% | -27,4 -35,9 23.69% | -36,9 -36,7 -0.5% | -67,3 -29,6 -127.46% | -44,7 | -36,3 | -17,4 | -13,1 | ||||
|
Net income Million USD | Released Forecast Spread | -11,2 -49,5 77.43% | -94,0 -65,1 -44.39% | -9,20 -52,8 82.56% | -9,82 -28,3 65.27% | -13,3 -27,1 50.93% | -25,5 -10,2 -149.66% | -22,3 | -17,5 | -15,9 | -9,89 | ||||
|
EPS USD | Released Forecast Spread | -0,27 -1,19 77.31% | -2,26 -1,56 -44.87% | -0,22 -0,68 67.41% | -0,09 -0,13 30.77% | -0,12 -0,22 45.45% | -0,22 -0,11 -100% | -0,13 | -0,11 | -0,09 | -0,06 | -0,16 | |||
| Announcement Date | 21/10/22 | 21/10/22 | 20/10/22 | 14/11/22 | 31/03/23 | 10/05/23 | 07/08/23 | 08/11/23 | 28/03/24 | - | - | - | - | - |
More events
Past sector events for P3 Health Partners Inc.
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PIII Stock
- Calendar P3 Health Partners Inc.
